Tech Company Financing Transactions
AN2 Therapeutics Funding Round
On 1/7/2022, AN2 Therapeutics raised $80 million in Series B funding from RA Capital, Avidity Partners and BVF Partners.
Transaction Overview
Company Name
Announced On
1/7/2022
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
171 Forest Ln.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Not Recorded
Overview
AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eric Easom
Chief Financial Officer
Lucy Day
Chief Financial Officer
Paul Eckburg
Co-Founder
Michael Alley
Vice President
Vince Hernandez
VP - Bus. Development
Sanjay Chanda
VP - Manufacturing
Kieron Wesson
VP - Operations
Kevin Krause
Browse more venture capital transactions:
Prev: 1/7/2022: Alto IRA venture capital transaction
Next: 1/7/2022: mPharma Data venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs